Astrazeneca (AZN) Price to Book (2009 - 2026)

Astrazeneca has reported Price to Book for 18 years, with the latest figure at 5.84 in Q2 2026.

• On a quarterly basis, Price to Book rose 20.7% year-over-year to 5.84 in Q2 2026; TTM through Jun 2026 was 5.84, a 20.7% increase from a year earlier, with the FY2025 full-year figure at 5.85, up 17.71% from the prior year.
• Price to Book was 5.84 for Q2 2026 at Astrazeneca, down from 6.45 in the prior quarter.
• The five-year high for Price to Book was 6.45 in Q1 2026, with the low at 4.83 in Q3 2022.
• Average Price to Book over 5 years is 5.61, with a median of 5.66 recorded in 2022.
• The largest YoY upside for Price to Book was 23.28% in 2022 against a maximum downside of 43.14% in 2022.
• Over 5 years, Price to Book stood at 5.66 in 2022, then slipped by 5.95% to 5.33 in 2023, then declined by 6.72% to 4.97 in 2024, then gained by 17.71% to 5.85 in 2025, then declined by 0.25% to 5.84 in 2026.
• The last three Price to Book figures came in at 5.84 (Q2 2026), 6.45 (Q1 2026), and 5.85 (Q4 2025), per Business Quant data.